A detailed history of Inscription Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Inscription Capital, LLC holds 1,472 shares of BDX stock, worth $340,355. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,472
Previous 1,455 1.17%
Holding current value
$340,355
Previous $340,000 4.12%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$221.47 - $242.41 $3,764 - $4,120
17 Added 1.17%
1,472 $354,000
Q1 2024

Apr 10, 2024

BUY
$233.45 - $247.73 $136,568 - $144,922
585 Added 67.24%
1,455 $360,000
Q1 2023

May 02, 2023

BUY
$229.71 - $259.35 $6,891 - $7,780
30 Added 3.57%
870 $215,000
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $183,363 - $215,804
840 New
840 $213,000
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $42,865 - $221,953
-840 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $28,749 - $31,916
-118 Reduced 12.32%
840 $223,000
Q4 2021

Feb 10, 2022

BUY
$230.08 - $250.94 $27,149 - $29,610
118 Added 14.05%
958 $241,000
Q3 2021

Nov 09, 2021

SELL
$232.72 - $256.47 $7,447 - $8,207
-32 Reduced 3.67%
840 $206,000
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $7,444 - $8,146
32 Added 3.81%
872 $212,000
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $186,412 - $206,589
840 New
840 $210,000
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $181,246 - $232,478
-840 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$219.9 - $263.41 $22,869 - $27,394
-104 Reduced 11.02%
840 $201,000
Q3 2019

Nov 01, 2019

BUY
$230.58 - $256.08 $217,667 - $241,739
944 New
944 $239,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $31,523 - $35,681
-145 Closed
0 $0
Q4 2018

May 16, 2019

BUY
$204.73 - $257.93 $29,685 - $37,399
145 New
145 $33,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.